One Hundred False-Positive Amphetamine Specimens Characterized by Liquid Chromatography Time-of-Flight Mass Spectrometry.

Some amphetamine (AMP) and ecstacy (MDMA) urine immunoassay (IA) kits are prone to false-positive results due to poor specificity of the antibody. We employed two techniques, high-resolution mass spectrometry (HRMS) and an in silico structure search, to identify compounds likely to cause false-positive results. Hundred false-positive IA specimens for AMP and/or MDMA were analyzed by an Agilent 6230 time-of-flight (TOF) mass spectrometer. Separately, SciFinder (Chemical Abstracts) was used as an in silico structure search to generate a library of compounds that are known to cross-react with AMP/MDMA IAs. Chemical formulas and exact masses of 145 structures were then compared against masses identified by TOF. Compounds known to have cross-reactivity with the IAs were identified in the structure-based search. The chemical formulas and exact masses of 145 structures (of 20 chemical formulas) were compared against masses identified by TOF. Urine analysis by HRMS correlates accurate mass with chemical formulae, but provides little information regarding compound structure. Structural data of targeted antigens can be utilized to correlate HRMS-derived chemical formulas with structural analogs.

[1]  Octavia M Peck Palmer,et al.  Ranitidine interference with standard amphetamine immunoassay. , 2015, Clinica chimica acta; international journal of clinical chemistry.

[2]  Robert L Fitzgerald,et al.  False-positive interferences of common urine drug screen immunoassays: a review. , 2014, Journal of analytical toxicology.

[3]  T. Villén,et al.  Detectability of new psychoactive substances, 'legal highs', in CEDIA, EMIT, and KIMS immunochemical screening assays for drugs of abuse. , 2014, Drug testing and analysis.

[4]  Kayla N. Ellefsen,et al.  Simultaneous quantification of 28 synthetic cathinones and metabolites in urine by liquid chromatography-high resolution mass spectrometry , 2013, Analytical and Bioanalytical Chemistry.

[5]  D. Black,et al.  Pseudoephedrine and False‐Positive Immunoassay Urine Drug Tests for Amphetamine , 2013, Pharmacotherapy.

[6]  Y. Kaplan,et al.  False-positive amphetamine/ecstasy (MDMA/3,4-methylenedioxymethamphetamine) (CEDIA) and ecstasy (MDMA/3,4-methylenedioxymethamphetamine) (DRI) test results with fenofibrate. , 2012, Therapeutic drug monitoring.

[7]  Gwendolyn A McMillin,et al.  Rapid screening for 67 drugs and metabolites in serum or plasma by accurate-mass LC-TOF-MS. , 2012, Journal of analytical toxicology.

[8]  Lindsay B. Curtin,et al.  Immunoassay Cross‐Reactivity of Phenylephrine and Methamphetamine , 2012, Pharmacotherapy.

[9]  J. Baron,et al.  The trazodone metabolite meta-chlorophenylpiperazine can cause false-positive urine amphetamine immunoassay results. , 2011, Journal of analytical toxicology.

[10]  H. Walls,et al.  Crossreactivity of Bupropion Metabolite With Enzyme-Linked Immunosorbent Assays Designed to Detect Amphetamine in Urine , 2011, Therapeutic drug monitoring.

[11]  J. Magluilo,et al.  Dimethylamylamine: a drug causing positive immunoassay results for amphetamines. , 2011, Journal of analytical toxicology.

[12]  L. Yee,et al.  False-Positive Amphetamine Toxicology Screen Results in Three Pregnant Women Using Labetalol , 2011, Obstetrics and gynecology.

[13]  M. Scott,et al.  Frequency of False Positive Amphetamine Screens due to Bupropion Using the Syva Emit II Immunoassay , 2011, Journal of Medical Toxicology.

[14]  B. Logan,et al.  Trazodone, meta-chlorophenylpiperazine (an hallucinogenic drug and trazodone metabolite), and the hallucinogen trifluoromethylphenylpiperazine cross-react with the EMIT®II ecstasy immunoassay in urine. , 2010, Journal of analytical toxicology.

[15]  R. Valdes,et al.  Digoxin immunoassay with cross-reactivity of digoxin metabolites proportional to their biological activity. , 1994, Clinical chemistry.